CLL: Indicated for the treatment of patients with chronic lymphocytic leukaemia.
NHL: Relapsed/Refractory indolent Non-Hodgkin's lymphoma.
Previously untreated NHL: Previously untreated indolent CD20-positive, stage III-IV Non-Hodgkin's lymphoma, in combination with rituximab.
Previously untreated MCL: Previously untreated CD20-positive, stage III-IV Mantle Cell Lymphoma in combination with rituximab, in patients ineligible for autologous stem cell transplantation.
Other Services
Country
Account